How does hepatitis C virus enter cells? von Diedrich, Gundo

Volltext

Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule von Berezhnoy, Alexey, Sumrow, Bradley J., Stahl, Kurt, Shah, Kalpana, Liu, Daorong, Li, Jonathan, Hao, Su-Shin, De Costa, Anushka, Kaul, Sanjeev, Bendell, Johanna, Cote, Gregory M., Luke, Jason J., Sanborn, Rachel E., Sharma, Manish R., Chen, Francine, Li, Hua, Diedrich, Gundo, Bonvini, Ezio, Moore, Paul A.

Volltext

Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART (R) Molecules von Pollara, Justin, Edwards, R. Whitney, Jha, Shalini, Lam, Chia-Ying Kao, Liu, Liqin, Diedrich, Gundo, Nordstrom, Jeffrey L., Huffman, Tori, Pickeral, Joy A., Denny, Thomas N., Permar, Sallie R., Ferrari, Guido

Volltext

The nature of the MHC class I peptide loading complex von Cresswell, Peter, Bangia, Naveen, Dick, Tobias, Diedrich, Gundo

Volltext

Abstract 1533: IMGC936, a first-in-class ADAM9-targeting antibody-drug conjugate, demonstrates promising anti-tumor activity von Hicks, Stuart, Loo, Deryk, Sinkevicius, Kerstin, Scribner, Juniper, Barat, Bhaswati, Yoder, Nicholas, Espelin, Christopher, Themeles, Marian, Chen, Francine, Lucas, Jacquelynn, Brown, Jennifer, Matin, Bahar, Fuller, Megan, Lee, Jenny, Salomon, Paulin, Costoplus, Juliet, Yancey, Sadiqa, Diedrich, Gundo, Gorlatov, Sergey, Son, Thomas, Chiechi, Michael, Li, Pam, Spliedt, Michael, Ciccarone, Valentina, Hooley, Jeff, Gantt, Nadia, Tamura, James, Donahue, Kerry, Moore, Paul, Johnson, Syd, Chittenden, Thomas, Gregory, Richard, Bonvini, Ezio

Volltext

Multispecific, Multivalent Antibody‐Based Molecules Engineered on the DART® and TRIDENTTM Platforms von Huang, Ling, Shah, Kalpana, Barat, Bhaswati, Lam, Chia‐Ying K., Gorlatov, Sergey, Ciccarone, Valentina, Tamura, James, Moore, Paul A., Diedrich, Gundo

Volltext

682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples von Berezhnoy, Alexey, Shah, Kalpana, Liu, Daorong, Lung, Peter, Long, Vatana, Stahl, Kurt, Smith, Douglas, Chen, Francine, Li, Hua, Li, Jonathan, Alderson, Ralph, Ciccarone, Valentina, Tamura, James, Bonvini, Ezio, Diedrich, Gundo, Moore, Paul

Volltext

A Role for Calnexin in the Assembly of the MHC Class I Loading Complex in the Endoplasmic Reticulum von Diedrich, Gundo, Bangia, Naveen, Pan, Mary, Cresswell, Peter

Volltext

Targeting CD73 in the tumor microenvironment with MEDI9447 von Hay, Carl M., Sult, Erin, Huang, Qihui, Mulgrew, Kathy, Fuhrmann, Stacy R., McGlinchey, Kelly A., Hammond, Scott A., Rothstein, Raymond, Rios-Doria, Jonathan, Poon, Edmund, Holoweckyj, Nick, Durham, Nicholas M., Leow, Ching Ching, Diedrich, Gundo, Damschroder, Melissa, Herbst, Ronald, Hollingsworth, Robert E., Sachsenmeier, Kris F.

Volltext

Combinatorial Anti-Tumor Activity in Animal Models of a Novel CD123 x CD3 Bispecific Dart® Molecule (MGD024) with Cytarabine, Venetoclax or Azacitidine Supports Combination Therapy... von Alderson, Ralph F., Huang, Ling, Zhang, Xiaoyu, Li, Haiquan, Kaufman, Thomas, Diedrich, Gundo, Moore, Paul, Bonvini, Ezio

Volltext

Identification of Specific Glycoforms of Major Histocompatibility Complex Class I Heavy Chains Suggests That Class I Peptide Loading Is an Adaptation of the Quality Control Pathway... von Radcliffe, Catherine M, Diedrich, Gundo, Harvey, David J, Dwek, Raymond A, Cresswell, Peter, Rudd, Pauline M

Volltext

Ribosomal protein L2 is involved in the association of the ribosomal subunits, tRNA binding to A and P sites and peptidyl transfer von Diedrich, Gundo, Spahn, Christian M. T., Stelzl, Ulrich, Schäfer, Markus A., Wooten, Tammy, Bochkariov, Dmitry E., Cooperman, Barry S., Traut, Robert R., Nierhaus, Knud H.

Volltext

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action von Geoghegan, James C, Diedrich, Gundo, Lu, Xiaojun, Rosenthal, Kim, Sachsenmeier, Kris F, Wu, Herren, Dall'Acqua, William F, Damschroder, Melissa M

Volltext

Abstract 2288: Investigational CD25 x CTLA-4 bispecific DART® molecule for depletion of tumor infiltrating Tregs via an enhanced Fc-dependent effector mechanism von Berezhnoy, Alexey, Shah, Kalpana, Liu, Daorong, Jill, Rillema, Fieger, Claudia, Smith, Douglas, Chen, Francine, Tamura, James, Bonvini, Ezio, Diedrich, Gundo, Moore, Paul A.

Volltext

REVIEW ARTICLE: How does hepatitis C virus enter cells? von Diedrich, Gundo

Volltext

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients von SPERINDE, Jeff, XUEGUANG JIN, FUCHS, Eva-Maria, SINGER, Christian F, KÖSTLER, Wolfgang J, BATES, Michael, PARRY, Gordon, WINSLOW, John, LIPTON, Allan, BANERJEE, Jayee, PENUEL, Elicia, SAHA, Anasuya, DIEDRICH, Gundo, WEIDONG HUANG, LEITZEL, Kim, WEIDLER, Jodi, ALI, Suhail M

Volltext

Preclinical Evaluation of IMGC936, a Next Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors von Scribner, Juniper A, Hicks, Stuart W, Sinkevicius, Kerstin W, Yoder, Nicholas C, Diedrich, Gundo, Brown, Jennifer G, Lucas, Jacquelynn, Fuller, Megan E, Son, Thomas, Dastur, Anahita, Hooley, Jeff, Espelin, Christopher W, Themeles, Marian, Chen, Francine Z, Li, Ying, Chiechi, Michael, Lee, Jenny, Barat, Bhaswati, Widjaja, Lusiana, Gorlatov, Sergey, Tamura, James, Ciccarone, Valentina, Ab, Olga, McEachem, Kerry A, Koenig, Scott, Westin, Eric H, Moore, Paul A, Chittenden, Thomas, Gregory, Richard J, Bonvini, Ezio, Loo, Deryk

Volltext

Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation von Liu, Liqin, Lam, Chia-Ying K., Alderson, Ralph, Long, Vatana, Yang, Yinhua, Burns, Robert, Widjaja, Lusiana, Li, Jonathan, Wolf, Christina, Ciccarone, Valentina, Tamura, James, Diedrich, Gundo, Bonvini, Ezio, Johnson, Syd, Moore, Paul A.

Volltext

Multispecific, Multivalent Antibody‐Based Molecules Engineered on the DART® and TRIDENT TM Platforms von Huang, Ling, Shah, Kalpana, Barat, Bhaswati, Lam, Chia‐Ying K., Gorlatov, Sergey, Ciccarone, Valentina, Tamura, James, Moore, Paul A., Diedrich, Gundo

Volltext

Abstract 38: Target validation, antibody discovery and preclinical data supporting ADAM9 as an antibody-drug conjugate therapeutic target for solid tumors von Scribner, Juniper A., Barat, Bhaswati, Hicks, Stuart W., Yoder, Nicholas C., Son, Thomas, Widjaja, Lusiana, Diedrich, Gundo, Gorlatov, Sergey, Hooley, Jeff, Easton, Ann, Lung, Peter, Costa, Anushka De, Chen, Francine, Chiechi, Michael, Li, Pam, Licea, Monica, Hotaling, Timothy E., Spliedt, Michael, Ciccarone, Valentina, Gantt, Nadia, Tamura, James, Fuller, Megan E., McShea, Molly, Koenig, Scott, Johnson, Syd, Moore, Paul A., Bonvini, Ezio, Loo, Deryk

Volltext